OverviewSuggest Edit

VolitionRx is a life sciences company which focuses on developing blood-based tests to diagnose a range of cancers. The Company is involved in the development of epigenetic Nu.Q blood assays based on its Nucleosomics biomarker discovery platform. It also develops HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to decide on appropriate therapy, NuQ tests for non-cancer conditions, and NuQ clinical diagnostic products. 

TypePublic
Founded2010
HQSingapore, SG
Websitevolitionrx.com

Latest Updates

Employees (est.) (Dec 2019)50(+14%)
Revenue (FY, 2019)$17.1 K(+16%)
Share Price (Sept 2020)$3 (+4%)
Cybersecurity ratingAMore

Key People/Management at VolitionRX

Cameron Reynolds

Cameron Reynolds

President & Chief Executive Officer
Martin C Faulkes

Martin C Faulkes

Executive Chairman
David Vanston

David Vanston

Group Chief Financial Officer
Alan Colman

Alan Colman

Non-Executive Director
Jake Micallef

Jake Micallef

Chief Scientific Officer
Edward Futcher

Edward Futcher

Non-Executive Director
Show more

VolitionRX Office Locations

VolitionRX has offices in Singapore, Austin, Isnes and London
Singapore, SG (HQ)
1 Scotts Road #24-05 Shaw Centre
Isnes, BE
22 Rue Phocas Lejeune Parc Scientifique Crealys
London, GB
93-95 Gloucester Place
Austin, US
100 Congress Ave
Show all (4)

VolitionRX Financials and Metrics

VolitionRX Revenue

VolitionRX's revenue was reported to be $17.10 k in FY, 2019
USD

Revenue (Q2, 2020)

5.2k

Net income (Q2, 2020)

(5.0m)

EBIT (Q2, 2020)

(5.2m)

Market capitalization (23-Sept-2020)

145.2m

Closing stock price (23-Sept-2020)

3.0

Cash (30-Jun-2020)

21.3m

EV

127.3m
VolitionRX's current market capitalization is $145.2 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

55.0k14.8k17.1k

Sales and marketing expense

666.4k763.4k1.2m965.7k

General and administrative expense

275.1k448.0k434.0k299.1k669.0k741.7k5.4m5.8m4.7m

R&D expense

1.5m2.8m2.5m4.0m6.1m6.8m8.9m10.9m10.4m
Quarterly
USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

15.7k11.7k27.6k14.8k17.1k544.05.2k

Sales and marketing expense

148.6k152.6k134.7k364.1k235.4k259.3k284.3k238.1k195.6k274.0k215.9k

General and administrative expense

44.9k149.1k48.2k51.6k123.1k68.0k68.9k51.8k129.3k247.8k122.4k141.4k228.2k166.1k163.9k244.2k258.7k226.6k1.8m1.6m1.5m1.2m1.4m1.4m1.7m1.5m

R&D expense

502.7k559.4k663.9k593.2k640.6k524.5k870.5k791.3k1.1m1.2m1.4m1.9m1.5m1.8m2.0m1.8m1.7m2.2m2.4m2.7m2.7m2.5m2.5m2.6m3.9m3.5m
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Cash

347.9k376.4k888.7k2.1m5.9m21.7m10.1m13.4m17.0m

Accounts Receivable

1.8m

Prepaid Expenses

320.8k28.5k82.1k144.1k152.9k248.7k245.4k267.5k

Inventories

USDFY, 2011

Financial Leverage

2.1 x
Show all financial metrics

VolitionRX Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

VolitionRX Online and Social Media Presence

Embed Graph

VolitionRX News and Updates

VolitionRx Limited Schedules Second Quarter 2020 Earnings Conference Call and Business Update

AUSTIN, Texas, Aug. 10, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call on Friday, August 14, at 8:30 a.m. Eastern time to discuss its financial and operating results for the second quarter 2020, in addition to...

VolitionRx Releases Business Update Video and Announces Addition to the Russell 3000® and Russell Microcap® Indexes

AUSTIN, Texas, June 25, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost-effective blood tests to help diagnose a range of cancers and other diseases, today released a business update...

VolitionRx Announces Pricing of Underwritten Public Offering of Common Stock

AUSTIN, Texas, May 20, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company that applies its NucleosomicsTM platform through its subsidiaries to develop simple, easy to use, cost-effective blood tests to help diagnose a range of...

VolitionRx Limited Announces Proof of Concept Data in Lymphoma and Leukemia

AUSTIN, Texas, Dec. 3, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced results from its latest proof of concept study. A single pre-clinical Nu.Q™ assay utilizing a basic microtiter plate platform detected 80% of newly diagnosed Non-Hodgkins...

VolitionRx Limited Announces Third Quarter 2019 Financial Results and Business Update

AUSTIN, Texas, Nov 13, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the third quarter ended September 30, 2019. Volition management will host a conference call tomorrow, November 13, at 8:30 a.m. U.S....

VolitionRx Limited Schedules Third Quarter 2019 Earnings Conference Call and Business Update

AUSTIN, Texas, Nov. 7, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE American: VNRX) ("Volition") today announced it will host a conference call on Wednesday, November 13 at 8:30 a.m. Eastern time to discuss its financial and operating results for the third quarter of 2019 in addition to...
Show more

VolitionRX Frequently Asked Questions

  • When was VolitionRX founded?

    VolitionRX was founded in 2010.

  • Who are VolitionRX key executives?

    VolitionRX's key executives are Cameron Reynolds, Martin C Faulkes and David Vanston.

  • How many employees does VolitionRX have?

    VolitionRX has 50 employees.

  • What is VolitionRX revenue?

    Latest VolitionRX annual revenue is $17.1 k.

  • What is VolitionRX revenue per employee?

    Latest VolitionRX revenue per employee is $342 .

  • Who are VolitionRX competitors?

    Competitors of VolitionRX include Xilio Therapeutics, Elypta and MiRXES.

  • Where is VolitionRX headquarters?

    VolitionRX headquarters is located at 1 Scotts Road #24-05 Shaw Centre , Singapore.

  • Where are VolitionRX offices?

    VolitionRX has offices in Singapore, Austin, Isnes and London.

  • How many offices does VolitionRX have?

    VolitionRX has 4 offices.